Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats

BMC Gastroenterology

Volumn 15, Issue 1, 2015, Pages

  Roberts, Michael D ^a,b   Mobley, C Brooks ^a   Toedebush, Ryan G ^c   Heese, Alexander J ^c   Zhu, Conan ^c   Krieger, Anna E ^c   Cruthirds, Clayton L ^c   Lockwood, Christopher M ^d   Hofheins, John C ^c   Wiedmeyer, Charles E ^c   Leidy, Heather J ^e   Booth, Frank W ^c,f   Rector, R Scott ^c,e,g  

^a AUBURN UNIVERSITY   (United States)

^b EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d 4Life Research   (United States)

^e University of Missouri   (United States)

^f UNIVERSITY OF MISSOURI   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fatty liver; High fat diet; Inflammation; RNA seq; Sucrose

Indexed keywords

ACYL COENZYME A DESATURASE; CHOLESTEROL; MESSENGER RNA; MINERAL; TRANSCRIPTOME; TRIACYLGLYCEROL; VITAMIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BROWN NORWAY RAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY LIVER; GENE; LIPID METABOLISM; LIVER LEVEL; MALE; MINERAL METABOLISM; NONHUMAN; RAT; RNA SEQUENCE; SCD GENE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; GENETICS; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; SEQUENCE ANALYSIS;

ANIMALS; CHOLESTEROL; DIET, WESTERN; LIPID METABOLISM; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; STEAROYL-COA DESATURASE; TRANSCRIPTOME; TRIGLYCERIDES;

EID: 84945540962     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-015-0382-3     Document Type: Article

References (51)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95. doi: 10.1002/hep.20466.
2. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132(2):112-7.
3. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol. 2008;14(2):185-92.
4. Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology. 2013;58(5):1632-43. doi: 10.1002/hep.26594.
5. Almon RR, DuBois DC, Lai W, Xue B, Nie J, Jusko WJ. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J Endocrinol. 2009;200(3):331-46. doi: 10.1677/JOE-08-0404.
6. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, Lee YS. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene. 2004;340(1):99-109. doi: 10.1016/j.gene.2004.06.015.
7. Kim S, Sohn I, Lee YS, Lee YS. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr. 2005;135(1):33-41.
8. Yang RL, Li W, Shi YH, Le GW. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition. 2008;24(6):582-8. doi: 10.1016/j.nut.2008.02.002.
9. Kim EJ, Kim E, Kwon EY, Jang HS, Hur CG, Choi MS. Network analysis of hepatic genes responded to high-fat diet in C57BL/6 J mice: nutrigenomics data mining from recent research findings. J Med Food. 2010;13(4):743-56. doi: 10.1089/jmf.2009.1350.
10. Mobley CB, Toedebusch RG, Lockwood CM, Heese AJ, Zhu C, Krieger AE, et al. Herbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-alpha expression and protein carbonylation in Western diet feeding in rats. Nutr Metab. 2014;11:19. doi: 10.1186/1743-7075-11-19.
11. VanSaun MN, Lee IK, Washington MK, Matrisian L, Gorden DL. High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol. 2009;175(1):355-64. doi: 10.2353/ajpath.2009.080703.
12. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem. 2009;284(9):5637-44. doi: 10.1074/jbc.M807616200.
13. Rector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):G619-26. doi: 10.1152/ajpgi.00428.2007..
14. Rustemeyer SM, Lamberson WR, Ledoux DR, Wells K, Austin KJ, Cammack KM. Effects of dietary aflatoxin on the hepatic expression of apoptosis genes in growing barrows. J Anim Sci. 2011;89(4):916-25. doi: 10.2527/jas.2010-3473.
15. Lu C, Kumar PA, Sun J, Aggarwal A, Fan Y, Sperling MA, et al. Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity. J Biol Chem. 2013;288(22):15725-35. doi: 10.1074/jbc.M113.460212.
16. Stanton MC, Chen SC, Jackson JV, Rojas-Triana A, Kinsley D, Cui L, et al. Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm. 2011;8:8. doi: 10.1186/1476-9255-8-8.
17. Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, et al. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2008;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.
18. Syn WK, Yang L, Chiang DJ, Qian Y, Jung Y, Karaca G, et al. Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. Liver Int. 2009;29(8):1262-72. doi: 10.1111/j.1478-3231.2009.02036.x.
19. Kang M, Li S, Zhong D, Yang Z, Li P. [Hepatocyte apoptosis and mitochondrial permeability transition pore opening in rats with nonalcoholic fatty liver]. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(7):1062-6.
20. Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr. 2008;138(10):1866-71.
21. Peter A, Cegan A, Wagner S, Elcnerova M, Konigsrainer A, Konigsrainer I, et al. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab. 2011;300(2):E321-6. doi: 10.1152/ajpendo.00306.2010.
22. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 2002;297(5579):240-3. doi: 10.1126/science.1071527.
23. Dobrzyn P, Dobrzyn A, Miyazaki M, Cohen P, Asilmaz E, Hardie DG, et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A. 2004;101(17):6409-14. doi: 10.1073/pnas.0401627101.
24. Miyazaki M, Sampath H, Liu X, Flowers MT, Chu K, Dobrzyn A, et al. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun. 2009;380(4):818-22. doi: 10.1016/j.bbrc.2009.01.183.
25. Beppu F, Hosokawa M, Yim MJ, Shinoda T, Miyashita K. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice. Lipids. 2013;48(5):449-55. doi: 10.1007/s11745-013-3784-4.
26. Xu H, Wilcox D, Nguyen P, Voorbach M, Smith H, Brodjian S, et al. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition. Front Biosci. 2007;12:3781-94.
27. Christianson JL, Nicoloro S, Straubhaar J, Czech MP. Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells. J Biol Chem. 2008;283(5):2906-16. doi: 10.1074/jbc.M705656200.
28. Wang H, Zhao Y, Bradbury JA, Graves JP, Foley J, Blaisdell JA, et al. Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities. Mol Pharmacol. 2004;65(5):1148-58. doi: 10.1124/mol.65.5.1148.
29. Collison KS, Maqbool Z, Saleh SM, Inglis A, Makhoul NJ, Bakheet R, et al. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res. 2009;50(8):1521-37. doi: 10.1194/jlr.M800418-JLR200.
30. Bennati AM, Castelli M, Della Fazia MA, Beccari T, Caruso D, Servillo G, et al. Sterol dependent regulation of human TM7SF2 gene expression: role of the encoded 3beta-hydroxysterol Delta14-reductase in human cholesterol biosynthesis. Biochim Biophys Acta. 2006;1761(7):677-85. doi: 10.1016/j.bbalip.2006.05.004.
31. Charlesworth JC, Peralta JM, Drigalenko E, Goring HH, Almasy L, Dyer TD, et al. Toward the identification of causal genes in complex diseases: a gene-centric joint test of significance combining genomic and transcriptomic data. BMC Proc. 2009;3 Suppl 7:S92.
32. Ballestri S, Day CP, Daly AK. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity. Gastroenterology. 2011;140(5):1694-5. doi: 10.1053/j.gastro.2011.01.060.
33. Vickers KC, Landstreet SR, Levin MG, Shoucri BM, Toth CL, Taylor RC, et al. MicroRNA-223 coordinates cholesterol homeostasis. Proc Natl Acad Sci U S A. 2014;111(40):14518-23. doi: 10.1073/pnas.1215767111.
34. Takaishi K, Duplomb L, Wang MY, Li J, Unger RH. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci U S A. 2004;101(18):7106-11. doi: 10.1073/pnas.0401715101.
35. Akram ON, Bernier A, Petrides F, Wong G, Lambert G. Beyond LDL cholesterol, a new role for PCSK9. Arterioscler Thromb Vasc Biol. 2010;30(7):1279-81. doi: 10.1161/ATVBAHA.110.209007.
36. Wang Q, Jiang L, Wang J, Li S, Yu Y, You J, et al. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology. 2009;49(4):1166-75. doi: 10.1002/hep.22774.
37. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211-23.
38. Koruk M, Taysi S, Savas MC, Yilmaz O, Akcay F, Karakok M. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol. 2003;14(1):12-7.
39. Bell LN, Vuppalanchi R, Watkins PB, Bonkovsky HL, Serrano J, Fontana RJ, et al. Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther. 2012;35(5):600-12.
40. Radonjic M, de Haan JR, van Erk MJ, van Dijk KW, van den Berg SA, de Groot PJ, et al. Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program. PLoS One. 2009;4(8):e6646. doi: 10.1371/journal.pone.0006646.
41. Zaldivar MM, Pauels K, von Hundelshausen P, Berres ML, Schmitz P, Bornemann J, et al. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology. 2010;51(4):1345-53. doi: 10.1002/hep.23435.
42. Dominguez M, Miquel R, Colmenero J, Moreno M, Garcia-Pagan JC, Bosch J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136(5):1639-50. doi: 10.1053/j.gastro.2009.01.056.
43. Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 2006;79(11):1100-7. doi: 10.1016/j.lfs.2006.03.021.
44. Padidar S, Farquharson AJ, Williams LM, Kelaiditi E, Hoggard N, Arthur JR, et al. Leptin up-regulates pro-inflammatory cytokines in discrete cells within mouse colon. J Cell Physiol. 2011;226(8):2123-30. doi: 10.1002/jcp.22546.
45. Rodrigues DF, Henriques MC, Oliveira MC, Menezes-Garcia Z, Marques PE, Souza Dda G, et al. Acute intake of a high-fructose diet alters the balance of adipokine concentrations and induces neutrophil influx in the liver. J Nutr Biochem. 2014;25(4):388-94. doi: 10.1016/j.jnutbio.2013.11.012.
46. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12(1):57-65.
47. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002;37(2):206-13.
48. Trak-Smayra V, Paradis V, Massart J, Nasser S, Jebara V, Fromenty B. Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int J Exp Pathol. 2011;92(6):413-21. doi: 10.1111/j.1365-2613.2011.00793.x.
49. Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lutjohann D, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 2008;48(2):474-86. doi: 10.1002/hep.22363.
50. Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, et al. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis. Exp Mol Pathol. 2006;81(3):202-10. doi: 10.1016/j.yexmp.2006.06.001.
51. Kirpich IA, Gobejishvili LN, Bon Homme M, Waigel S, Cave M, Arteel G, et al. Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. J Nutr Biochem. 2011;22(1):38-45. doi: 10.1016/j.jnutbio.2009.11.009.